Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long Non-Coding RNA Encoded by Infectious Bronchitis Virus Facilitates Viral Replication via Direct Interaction with G3BP2 and Expression Regulation of a Novel Host MicroRNA. | Vet Sci | 2026 | 41893633 | PubTator, text mining | PubMed |
| The Role of Protein Post-Translational Modifications in the Pathogenesis of Nephrolithiasis: Mechanistic Insights and Translational Potential. | Cells | 2026 | 41892343 | PubTator, text mining | PubMed |
| MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cells. | Oncol Rep | 2026 | 41891959 | PubTator, text mining | PubMed |
| Noncanonical role of KDM5C in conferring bortezomib resistance via the PERK‒Nrf2 axis in multiple myeloma. | Cell Death Dis | 2026 | 41872155 | PubTator, text mining | PubMed |
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| SERBP1 is required for efficient HR repair and cisplatin chemoresistance in lung adenocarcinoma. | Cell Death Discov | 2026 | 41856985 | PubTator, text mining | PubMed |
| Non-invasive host transcriptome and HPV oncogene expression map the molecular landscape of HPV-driven cervical lesions. | PLoS One | 2026 | 41855211 | PubTator, text mining | PubMed |
| FBXO3-mediated DUSP9 ubiquitination promotes leukemia stem cell maintenance and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. | Cell Rep Med | 2026 | 41850237 | PubTator, text mining | PubMed |
| IFFO1 inhibits breast cancer by coordinating mitochondrial fission and fatty acid synthesis via the LaminA/C-PGC1α axis. | Oncogenesis | 2026 | 41844580 | PubTator, text mining | PubMed |
| Discovery of the First-in-Class Protein Arginine Methyltransferase 1 PROTAC Degrader. | J Med Chem | 2026 | 41830641 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. | Mol Biomed | 2026 | 41806079 | PubTator, text mining | PubMed |
| Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC. | Cancer Sci | 2026 | 41801765 | PubTator, text mining | PubMed |
| Evaluation of Potential Therapeutic Targets for Bacterial Infectious Skin Diseases: A Proteome-Wide Mendelian Randomization Study. | Clin Cosmet Investig Dermatol | 2026 | 41799426 | PubTator, text mining | PubMed |
| Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy. | Pharm Sci Adv | 2026 | 41799416 | PubTator, text mining | PubMed |
| Arginine methylation-dependent stabilization of SUV39H1 promotes breast cancer growth. | Oncogene | 2026 | 41795022 | PubTator, text mining | PubMed |
| Hepatitis B virus, alcohol, and liver cancer. | Front Oncol | 2026 | 41788994 | PubTator, text mining | PubMed |
| Crosstalk between mitophagy and breast cancer: mechanisms of action and clinical applications. | J Cancer Res Clin Oncol | 2026 | 41764124 | PubTator, text mining | PubMed |
| LC-MS profiling of prmt-1 and prmt-5 knockout C. elegans reveals PRMT-1 substrates and global proteome remodeling. | bioRxiv | 2026 | 41756837 | PubTator, text mining | PubMed |
| PRMT1 regulates glioblastoma stemness and immunosuppression via nitric oxide metabolism: Multi-cohort analysis and experimental validation. | Nitric Oxide | 2026 | 41747856 | PubTator, text mining | PubMed |
| Synergistic Cellular Toxicity from Inhibition of Poly(ADP-ribose) Glycohydrolase (PARG) and Ubiquitin-Specific Protease 1 (USP1). | Toxics | 2026 | 41745836 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=3